Invest Michigan
  • Home
  • About
  • Team
  • Portfolio
  • Press
  • Contact
Significant Financial Event– After Invest Michigan has invested, either: 1) a Series A financing; 2) attracted a strategic investor; 3) has become net income positive; or 4) has been acquired.

Invest Michigan is a non-profit that invests in early-stage high tech businesses located in Michigan.  Since 2014, Invest Michigan has been one of Michigan’s more active technology investors and continues to seek new investment opportunities.

Learn More

Our Funds

ACTIVE

The Fund partners with early-stage technology company entrepreneurs by providing investment capital through multiple financing rounds.

FULLY INVESTED

The University Commercialization Fund invested in 14 early stage technology start-ups that originated from within universities in the state of Michigan.

About
Team
Portfolio

Recent News

Genomenon Accelerates Quest to Curate Entire Human Genome With Boston Genetics Acquisition

June 30, 2023

NEW YORK – In acquiring longtime partner Boston Genomics this week, Genomenon is stepping up its efforts to become the first entity to curate the entire human genome, though it may be the only one to have declared such an intention.

By adding Cambridge, Massachusetts-based Boston Genetics’ team of about 75 genetic scientists — and doubling its total headcount — Genomenon now claims to have an inside track toward its goal, which CEO Mike Klein said is intended to combine artificial intelligence and next-generation sequencing to accelerate diagnosis of rare diseases and inform drug discovery.

“We’ll organize all the disease-gene relationships, we’ll organize all the variant landscapes across every disease, to really provide the insight for precision medicin

[read more]

ONL Therapeutics Closes First Tranche of $15 Million Series C Financing to Advance Lead Compound into Phase 2 Clinical Trial

March 10, 2023

Funding supports Phase 2 clinical study of ONL1204 Ophthalmic Solution to evaluate safety and efficacy in patients with macula-off rhegmatogenous retinal detachment

ANN ARBOR, Mich., March 8, 2023 – ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today announced it has closed on the first tranche of a $15 million Series C Preferred Stock financing round. Proceeds from the financing will primarily support the advancement of ONL1204 Ophthalmic Solution into a Phase 2 clinical trial in patients with macula-off rhegmatogenous retinal detachment (RRD).

“With the support of our current and new investors, coupled with the openin

[read more]

Zeeland furniture startup in ‘launch and accessibility mode’ after $1.5M capital raise

Mark Sanchez / August 8, 2022

A Zeeland furniture startup that seeks to play into the growing home office trend has secured $1.5 million in capital from investors around Michigan.

Quint Workspaces LLC, formed in 2020 by office furniture industry veteran Don Goeman, plans to use the early-stage funding to support new product development, expand delivery services to major markets, and enhance e-commerce capabilities.

“This round of funding moves Quint fully into launch and accessibility mode allowing us to quickly deliver affordable, high quality products to our new and existing customers,” said Goeman, the founder and CEO of Quint Workspaces who intends to open a new office and production facility in West Michigan later this year.

“The value of our products and

[read more]
All posts

131 Investments

56 Michigan Companies

Contact

Contact

Invest Michigan
235 E. Main Street, Suite 105B
Northville, MI 48167
Email info@investmichigan.org
© 2023 Invest Michigan Powered by Jottful